2025 NHS 13th Annual Meeting - Call for Abstracts Logo
  • NHS 13th Annual Meeting - Call for Abstracts

    Deadline to submit: July 1, 2025
  • Thank you for submitting an abstract for consideration at the upcoming Neurohospitalist Society Annual Meeting. Your contributions are vital in shaping the educational and scientific program, and we especially encourage young investigators, fellows, and residents to take advantage of this opportunity to showcase their work on a national stage. Presenting at the annual meeting is a valuable experience to gain recognition, receive feedback from experts, and connect with leaders in neurohospitalist medicine.

    As we review submissions, we kindly remind potential presenters that participation requires in-person attendance in Denver, CO, on October 17-18, 2025. We look forward to an engaging and collaborative meeting and appreciate your commitment to advancing the field.

  • Eligible Abstract Submissions:

    • Eligible abstracts are those that have not been published in a peer reviewed journal prior to July 1, 2025.
    • Submissions presented at other organizations' meetings in the past year are eligible.
    • Abstracts that are not copyrighted are eligible for submission.
    • The submitting author is to check whether material is copyrighted.
    • Abstracts are limited to 350 words.

    Oral Abstracts:

    Two submitted abstracts will be selected by the abstract reviewers for oral presentation to the general NHS assembly during the conference.

    Abstract Categories:

    Research: Abstracts reporting clinical or basic science research as well as systematic reviews of a clinical problem. Also included and encouraged are quality improvement and patient safety research.

    Innovations: Abstracts describing innovative programs in inpatient neurology and care delivery are encouraged under this category. Innovations are primarily descriptive and may include preliminary data. Please note that all innovation submissions must report an activity that has already been piloted or implemented in the health care setting. Innovations include: clinical pathway development, medical education, faculty development, computerized medical records, billing and collections, patient safety, communications, care team coordination.

    Clinical Vignettes: These abstracts are reports of one or more cases that illustrate a new disease entity or unusual clinical feature of an established disease, highlight an area of clinical controversy or illustrate a unique patient safety issue. It should include a summary of pertinent patient history, physical findings, laboratory data, management description and it should be clear why the vignette is relevant to inpatient neurology.

  • The presenting author (preferably the first author) must be available to present the abstract in person at the NHS Annual Meeting on October 17-18, 2025, in Denver, CO.

    All trainees who are first authors of accepted posters and presenting in person at the conference will receive complimentary, non-transferrable meeting registration (a discount code will be provided upon acceptance). Poster presenters are responsible for travel expenses, hotel, poster printing/preparation, and other associated costs.

    Acceptance notifications will be emailed on August 1, 2025. Authors will have until August 15, 2025, to accept the invitation to present their poster in person at the annual meeting. Acceptance will be considered a commitment to attend the in-person meeting and present the poster. The poster session will occur on both days of the annual meeting, with oral abstracts presented on Saturday, October 18.

    We recognize that emergencies arise. If you choose to withdraw your poster after the deadline, please contact NHS no later than September 1, 2025, at info@neurohospitalistsociety.org. 

  • 0/30
  • Research abstracts should use the following headings: Background, Methods, Results, Conclusions (Do not use the phrase "The results will be discussed.")

    Innovation abstracts should use the following headings: Background, Purpose, Description, Conclusions

    Clinical vignettes should use the following headings: Case Presentation, Discussion, Conclusions

  • 0/350
  • AUTHORS

    Please list all authors in order of authorship. The maximum number of authors this form will accept is 8. If you would like to list additional authors beyond 8, please make a note of each additional author's name, degree, affliation, and statement of conficts of interest in the text box at the end of the authorship section.

    Author/Submitter Responsibility:

    The first author/presenter should be a member of the NHS or in the process of membership application. If selected, the first author will present the poster at the in-person annual NHS meeting. Other authors need not be NHS members.

    Conflicts of Interest Policy:

    The Neurohospitalist Society promotes improved inpatient care, teaching and research in the field of hospital neurology. All authors submitting abstracts are required to disclose any relationships with pharmaceutical companies, biomedical device manufacturers or other organizations that could represent potential conflicts in their presentation. The first-author/presenting author is responsible for providing disclosure information for all co-authors in relation to the abstract entry.

    • AUTHOR #2 INFORMATION 
    • AUTHOR #3 INFORMATION 
    • AUTHOR #4 INFORMATION 
    • AUTHOR #5 INFORMATION 
    • AUTHOR #6 INFORMATION 
    • AUTHOR #7 INFORMATION 
    • AUTHOR #8 INFORMATION 
    • ADDITIONAL AUTHORS 
    • end sections 
    • CORRESPONDING AUTHOR

      Please provide the name and address or the author who will receive all communications regarding the abstract. It is the corresponding author's responsibility to communicate all notifications to co-authors, to accept/decline the invitation to present the abstract, and to withdraw the abstract if applicable.

    • Adherence to ethical standards of research and copyright: Local institutional review board approval must be obtained for any research involving human or animal subjects. The authors must affirm here that the study was approved by the appropriate committee.

    • Should be Empty: